We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+2.89%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$771M
AUM Growth
+$32.5M
Cap. Flow
+$15.2M
Cap. Flow %
1.97%
Top 10 Hldgs %
16.24%
Holding
916
New
72
Increased
419
Reduced
247
Closed
78

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$1.52M
2
VST icon
Vistra
VST
+$1.08M
3
ETP
Energy Transfer Partners, L.P.
ETP
+$1,000K
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$971K
5
AAPL icon
Apple
AAPL
+$804K

Top Sells

Rank Stock Value
1
TRR
Trc Companies
TRR
+$9.24M
2
GGP
GGP Inc.
GGP
+$1.5M
3
CNA icon
CNA Financial
CNA
+$1.04M
4
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$779K
5
CVS icon
CVS Health
CVS
+$759K

Sector Composition

Rank Sector Weight
1 Financials 10.7%
2 Healthcare 10.11%
3 Consumer Discretionary 9.02%
4 Technology 8.48%
5 Industrials 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLX icon
801
Protalix BioTherapeutics
PLX
$191M
$19K ﹤0.01%
+2,300
New +$21.6K
TPST icon
802
Tempest Therapeutics
TPST
$14.8M
$19K ﹤0.01%
4
– –
AXAS
803
DELISTED
Abraxas Petroleum Corp
AXAS
$17K ﹤0.01%
+525
New +$19.7K
ERN
804
DELISTED
Erin Energy Corp
ERN
$15K ﹤0.01%
10,000
-1,217
-11% -$2.25K
ATXS
805
DELISTED
Astria Therapeutics
ATXS
$14K ﹤0.01%
+170
New +$14.2K
PPP
806
DELISTED
Primero Mining Corp
PPP
$11K ﹤0.01%
31,170
+2,925
+10% +$1.33K
BIOL
807
DELISTED
Biolase, Inc.
BIOL
$10K ﹤0.01%
1
– –
VXRT
808
DELISTED
Vaxart
VXRT
$9K ﹤0.01%
1,285
+330
+35% +$1.97K
MTEM
809
DELISTED
Molecular Templates, Inc.
MTEM
$9K ﹤0.01%
135
– –
SDRL
810
DELISTED
Seadrill Limited Common Stock
SDRL
$6K ﹤0.01%
57
-36
-39% -$5.65K
PLM
811
DELISTED
PolyMet Mining Corp.
PLM
$6K ﹤0.01%
1,050
– –
DNN icon
812
Denison Mines
DNN
$2.63B
$4K ﹤0.01%
10,000
– –
C.WS.A
813
DELISTED
Citigroup Inc
C.WS.A
$2K ﹤0.01%
10,000
– –
ABUS icon
814
Arbutus Biopharma
ABUS
$865M
– –
-18,045
Closed -$59K
ADVM
815
DELISTED
Adverum Biotechnologies
ADVM
– –
-1,750
Closed -$47K
BGS icon
816
B&G Foods
BGS
$285M
– –
-7,496
Closed -$302K
BHC icon
817
Bausch Health
BHC
$1.65B
– –
-18,846
Closed -$208K
CNA icon
818
CNA Financial
CNA
$14.5B
– –
-23,550
Closed -$1.04M
CSIQ icon
819
Canadian Solar
CSIQ
$906M
– –
-15,400
Closed -$189K
CUBI icon
820
Customers Bancorp
CUBI
$2.59B
– –
-6,830
Closed -$215K
DOC icon
821
Healthpeak Properties
DOC
$15.4B
– –
-12,240
Closed -$383K
EOS
822
Eaton Vance Enhance Equity Income Fund II
EOS
$1.14B
– –
-13,004
Closed -$176K
EWZ icon
823
iShares MSCI Brazil ETF
EWZ
$9.05B
– –
-10,413
Closed -$390K
FXN icon
824
First Trust Energy AlphaDEX Fund
FXN
$398M
– –
-11,110
Closed -$167K
GGB icon
825
Gerdau
GGB
$9.44B
– –
-13,860
Closed -$38K
31 32
33
34 35

Similar funds

CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.44B AUM 125.26% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return

Wedbush Securities's Q2 2017 Portfolio in Review

As of Q2 2017, Wedbush Securities held 916 positions worth $771M, up 4.4% from $738M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Wedbush Securities's Q2 2017 filing shows 72 new, 419 increased, 247 reduced and 78 closed positions. Its largest new stake was Novo Nordisk: 75,326 shares worth $1.61M. The largest sale was Trc Companies, an estimated $9.24M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Wedbush Securities's largest Q2 2017 buy was Novo Nordisk: 75,326 shares worth $1.61M.
  • Wedbush Securities added most to Apple in Q2 2017, an estimated $804K increase.
  • Wedbush Securities's biggest Q2 2017 reduction was GGP Inc., cutting an estimated $1.5M.
  • Wedbush Securities fully exited Trc Companies in Q2 2017, selling an estimated $9.24M.
  • Wedbush Securities's ten largest holdings make up 16% of its $771M portfolio in Q2 2017.
  • Wedbush Securities opened 72 new positions and closed 78 in Q2 2017.
  • Wedbush Securities's portfolio value rose 4.4% quarter-over-quarter to $771M.

Based on Wedbush Securities's 13F filing for Q2 2017, filed 2 Aug 2017.